The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 500 Rutherford Ave, Boston,massachusetts 02129,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.xellarbio.com
- Keywords
- Artificial Intelligence, High Throughput Screening, Organ-on-chip, Morphological Profiling, Image-based Drug Discovery, Lab Automation, microfluidics, 3D cell culture, Micro-physiological Systems, Disease Modeling, Machine Learning.
- HQ
- Boston, Massachusetts
Xellar Biosystems Questions
Xellar Biosystems's website is http://www.xellarbio.com
Xellar Biosystems's LinkedIn profile is https://www.linkedin.com/company/xellar-biosystems
Xellar Biosystems has
20 employees.
View email and phone details for 20
employees at Xellar Biosystems.
Xellar Biosystems's industry is
Biotechnology Research
Xellar Biosystems's top competitors are
Quris Ai,
Applied Medical,
Insilico Medicine,
Emulate, Inc.,
Xbiome,
Probius,
Sciegen Pharmaceuticals Inc,
Xellar,
Receptor.ai,
Biocytogen.
Xellar Biosystems's categories are Biotechnology Research
Xellar Biosystems's founding year is 2022
